What Photobiomodulation Treats
Strong Areas Historically Known for Successful Treatment
Pain (e.g., back/neck, hips, elbows, shoulders, wrists, knees)
Wounds (e.g., diabetic ulcers, lacerations post-surgical closure)
Oncology side effects (e.g., mucositis), and hair loss/AMD (FDA-cleared). Safety: excellent profile (mild warmth); no serious events in >1,000 exposures. Contraindications: direct over tumors (except palliation), epilepsy.
Acute and chronic pain (neck, low back, knees, hips, osteoarthritis
Temporomandibular disorders (TMJ)
Long-COVID symptoms
Tendinopathies (Achilles, lateral elbow, rotator cuff, patellar)
Oral mucositis prevention/treatment in cancer patients
Wound healing (diabetic ulcers, venous ulcers, pressure ulcers)
Osteoarthritis (knee, hand, spine)
Post-operative pain and swelling (dental surgery, orthopedic surgery)
Lymphedema (breast-cancer-related)
Androgenetic alopecia (hair regrowth, FDA-cleared devices)
Inflammatory acne (especially red + near-infrared combinations)
Chronic low back pain (disc herniation, vertebral fractures, non-specific)
Neuropathic pain (diabetic neuropathy, chemotherapy-induced, post-herpetic neuralgia)
Thyroiditis (Hashimoto’s) – reduced antibody levels and levothyroxine dose
Female sexual dysfunction and vaginal atrophy (post-menopause or breast cancer)
Skin rejuvenation (wrinkles, scars, psoriasis, vitiligo, breast and face elasticity)
COVID-19 acute respiratory distress (several trials showed reduced intubation rates)
Cartilage regeneration (osteoarthritis, meniscal tears, rotor cuff tears, etc.)
Bone fracture healing and osteoporosis, post-surgical (example: knee, hip replacement)
Gut microbiome modulation and inflammatory bowel disease
Mild to moderate depression and anxiety (transcranial PBM)
Cognitive enhancement and mild cognitive impairment
Burns and skin graft healing
Dyskinesia (involuntary movement)
Tourette’s Syndrome; dramatic “tics” reduction, dramatic reduction in accompanying Obsessive Compulsive Disorder, dramatic reduction in nightmares (“dramatic reduction” defined: one patient with an average of 300 “tics” per day dropped to 1-2/day on average in just five months of treatments)
Traumatic brain injury (TBI), concussion – acute and chronic symptoms
Herpes labialis (cold sores), including recurrence reduction
Chronic nightmares
Insomnia
Veterinary applications (dogs, horses, kangaroos, cats – arthritis, wounds, etc.)
Strong Evidence of Efficacy (Multiple positive Random Control Trials, systematic reviews favorable)
Fibromyalgia pain and fatigue
Plantar fasciitis
Carpal tunnel syndrome
Bell’s palsy (facial nerve recovery)
Rheumatoid arthritis (hand and knee)
Post-stroke recovery (motor function, spasticity)
Dental conditions: dentin hypersensitivity, orthodontic pain, periodontal disease, aphthous ulcers
Early/Preclinical Evidence of Efficacy
Autism spectrum disorder symptoms (transcranial)
Multiple sclerosis symptoms
Spinal cord injury recovery
Liver regeneration and fatty liver disease
Kidney protection (contrast-induced nephropathy, chronic kidney disease)
Fertility (sperm motility, PCOS ovarian function)
Emerging Evidence of Efficacy
Alzheimer’s and Parkinson’s disease (transcranial studies)
Macular degeneration and retinopathy
Tinnitus
Chronic obstructive pulmonary disease (COPD) – exercise capacity
Muscle recovery and performance in athletes (reduced DOMS, faster strength recovery)